A detailed history of Transamerica Financial Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 104 shares of DXCM stock, worth $7,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 48,000 99.78%
Holding current value
$7,543
Previous $5.44 Million 99.87%
% of portfolio
0.0%
Previous 0.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $3.07 Million - $5.56 Million
-47,896 Reduced 99.78%
104 $7,000
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $4.98 Million - $6.11 Million
43,635 Added 999.66%
48,000 $6.66 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $329,513 - $541,958
4,365 New
4,365 $542,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.